Linksbridge expands the capacity of NGOs, IGOs, and nonprofits to improve human lives.
Joined January 2010
- Tweets 951
- Following 227
- Followers 188
- Likes 38
297 Photos and videos
7 Feb 2025
Linksbridge will no longer post updates on this platform. We invite you to follow us on LinkedIn or Bluesky. Visit our website for more. āš½
57
6 Feb 2025
Just four days after an Ebola outbreak was declared in Uganda, a trial to evaluate a vaccine against the disease has begun. This week's highlights explore the rapid launch of the study and more.
linkedin.com/pulse/linksbridā¦
91
30 Jan 2025
Essential medicines remain unavailable and unaffordable for a large portion of the worldāan "important violation of human rights" that requires urgent, comprehensive actionāaccording to a new analysis out this month.
linkedin.com/pulse/linksbridā¦
34
23 Jan 2025
The U.S. government recently doled out fresh funding for pandemic vaccine and therapeutic development, a tranche of which will go to Moderna for an mRNA-based H5N1 influenza vaccine.
linkedin.com/pulse/linksbridā¦
67
17 Jan 2025
Since 2019, Linksbridge has tracked over 180 planned integrated campaign deliveriesāincluding Madagascar's polio/measles vaccination effort.
Linksbridge'sĀ Campaigns Hub provides health campaign data for over 20 interventions. Access it here: bit.ly/4gSTo1E
22 Dec 2024
Madagascar successfully vaccinated millions of children against polio & measles this fall, protecting them from the devastating, preventable diseases. Through integrated efforts such as these, a healthier, polio-free world is #HumanlyPossible. Learn more: adobe.ly/3P6R1fB
1
248
16 Jan 2025
Regional manufacturing efforts got a boost in recent days via two initiatives aiming to drive local PCV production. More on these initiatives and other pharma news important to global health in this weekās highlights. linkedin.com/pulse/linksbridā¦
27
15 Jan 2025
In 2022, Linksbridge collaborated with the Gates Foundation and other stakeholders to create materials in support of the market entry and scale-up of Wolbachia replacement technology. The forecast's methods and results are available as global public goods: bit.ly/4aioDAQ
2 Jan 2025
The @WMPglobal has helped protect more than 11 million people in 14 countries from diseases like dengue. How?
By growing millions of mosquitoes.
@ScottLOneill, the programmeās founder, explains how their method works in āBehind the Researchā ā¤µļø
linkedin.com/pulse/millions-ā¦
41
13 Jan 2025
Nigeria has launched its first malaria vaccination campaign for children. More on this effort and campaigns across Africa, Asia, and Latin America in our latest health campaigns roundup. linkedin.com/pulse/health-caā¦
28
9 Jan 2025
Progress for malaria control and elimination efforts were key themes in our first issue of 2025. Explore these developments and more in this week's highlights.
linkedin.com/pulse/linksbridā¦
23
19 Dec 2024
Our last issue of 2024 covers a little bit of everything. We highlight mpox vaccine manufacturing, promising Phase 2b results for a blood-stage malaria vaccine, news from Institut Pasteur de Dakar's centenary celebration, and more.
linkedin.com/pulse/linksbridā¦
43
12 Dec 2024
WHO has granted prequalification to the first test for TB diagnosis and antibiotic susceptibility testing. In this week's highlights, we explore this critical milestone, the first regulatory nod forĀ moxidectin in a river blindness-endemic country, and more.linkedin.com/pulse/linksbridā¦
31
9 Dec 2024
In this month's roundup of campaign news, we highlight polio and cholera outbreak response efforts, integrated campaigns delivering vaccines, vitamin A supplements and deworming treatments, and HPV campaigns targeting children in Africa and Asia.
linkedin.com/pulse/health-caā¦
34
5 Dec 2024
This weekās highlights explore promising clinical trial results for a novel TB regimen, Unitaidās pledge to accelerate access to HIV PrEP drug lenacapavir, funds for global health vaccine R&D, developments in the African manufacturing space, and more. linkedin.com/pulse/linksbridā¦
64
28 Nov 2024
Drug and vaccine R&D investments were front and center in this week's highlights. Dyadic won backing for malaria and RSV mAbs development, Insud scored funds for a postpartum hemorrhage treatment trial in LMICs, and more.
linkedin.com/pulse/linksbridā¦
37
21 Nov 2024
Novartis dethroned eight-time-front-runner GSK in the 2024 Access to Medicine Index. In this weekās highlights, we dive into AtM's ranking of leading pharma companiesā efforts to provide access to their products in LMICs and more. linkedin.com/pulse/linksbridā¦
32
14 Nov 2024
New trials for mpox countermeasures are in the works. Catch up on these developments and other news related to H5N1, HIV, TB and TCV in this week's highlights. linkedin.com/pulse/linksbridā¦
71
8 Nov 2024
In this month's roundup of campaign news, we highlight polio vaccination campaigns in Afghanistan, Kenya, Pakistan, and Uganda and spotlight integrated campaigns in Nigeria. linkedin.com/pulse/health-caā¦
30
7 Nov 2024
WHO released a list identifying 17 endemic pathogens as top priorities for new vaccine development. More on the list and other pharma news important to global health in this week's highlights.
linkedin.com/pulse/linksbridā¦
20
31 Oct 2024
Several malaria-related news items caught our eye this week: MMV launched a first-in-human trial of a potential "game changer" antimalarial and WHO prequalified GSK'sĀ P. vivax treatment tafenoquine. More, in this week's highlights. linkedin.com/pulse/linksbridā¦
26
24 Oct 2024
In this week's highlights, we cover Rwanda's launch of the first clinical trial of a Marburg virus treatment, WHO's prequalificationĀ of a fourth TCV, the U.S. FDA's expanded approval of Pfizer's RSV vaccine, and more.
linkedin.com/pulse/linksbridā¦
66